术后血糖变异性增高与假体周围感染二期翻修术后不良结局相关
该回顾性研究纳入341例因假体周围感染接受二期翻修术的患者,分析再植入术后血糖变异系数与不良结局的关系。结果显示血糖变异性每增加1个标准差(15%),治疗失败、再感染和再手术风险分别增加27%、31%和26%,且该关联在非糖尿病患者中更显著。
要点
- 术后血糖变异系数每升高15%,治疗失败风险增加27%。
- 再感染和再手术风险分别增加31%和26%。
- 血糖变异性与不良结局的关联在非糖尿病患者中更显著。
核心结论
- 较高的术后血糖变异性与假体周围感染二期翻修术后治疗失败、再感染和再手术风险增加相关。
- 与非糖尿病患者相比,糖尿病患者中血糖变异性与不良结局的关联较弱。
研究设计与样本
- 回顾性队列研究,纳入2000至2017年因膝或髋假体周围感染接受二期翻修术的665例患者。
- 最终分析341例,纳入标准为随访至少1年且再植入期间每日至少2次血糖值或总共大于3次血糖值。
- 血糖变异性通过变异系数评估,不良结局包括根据Delphi共识标准定义的治疗失败、再感染、再手术和死亡率。
- 按有无糖尿病进行亚组分析,其中糖尿病患者81例,非糖尿病患者260例。
主要发现
- 再植入术后血糖变异性与较高的治疗失败、再感染和再手术风险相关。
- 校正分析显示,血糖变异系数每增加1个标准差(15%),治疗失败风险增加27%,再感染风险增加31%,再手术风险增加26%。
- 在非糖尿病患者中这些关联仍然稳健,但在糖尿病患者中不显著。
关键数值与推荐
- 血糖变异性以变异系数评估,每增加1个标准差为15%。
- 治疗失败定义依据Delphi共识标准。
- 不良结局包括治疗失败、再感染、再手术和死亡率。
临床怎么用
- 对于接受二期翻修术的假体周围感染患者,术后应密切监测血糖并严格控糖以减少血糖波动。
- 非糖尿病患者同样需要关注术后血糖变异性,因其与不良结局的关联更强。
局限性
- 回顾性研究设计。
- 仅纳入再植入期间血糖监测符合特定标准的患者,可能存在选择偏倚。
- 糖尿病亚组样本量较小(81例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glucose variability in the postoperative period has been associated with increased rates of periprosthetic joint infection (PJI) following primary arthroplasty. It is unknown how postoperative glucose control affects outcome of surgical treatment of PJI patients. We hypothesized that postoperative glucose variability adversely affects the outcome of 2-stage exchange arthroplasty. METHODS: We retrospectively reviewed records of 665 patients with PJI of the knee and hip who underwent 2-stage exchange arthroplasty from 2000 to 2017. Of them, 341 PJIs with a minimum follow-up of 1 year, and either a minimum of 2 glucose values per day or greater than 3 overall during the reimplantation were included. Glucose variability was assessed by calculating the coefficient of variation. Adverse outcomes included treatment failure according to the Delphi consensuses criteria, reinfection, reoperation, and mortality. A subgroup analysis was performed based on patients with or without diabetes. RESULTS: Glucose variability following reimplantation was associated with higher treatment failure, reinfection, and reoperation. Adjusted analysis indicated that for every standard deviation (15%) increase in the coefficient of variation, the risks of treatment failure, reinfection, and reoperation increased by 27%, 31%, and 26%. Although stratifying patients with (n = 81) or without diabetes (n = 260), these associations remained robust in nondiabetic patients, but not in diabetic patients. CONCLUSION: Higher glucose variability is associated with increased risks of treatment failure, reinfection, and reoperation after 2-stage exchange arthroplasty in PJI patients. Compared to diabetic patients, nondiabetic patients have a higher association between glucose variability and poor outcomes. Reducing adverse outcomes may be achieved with close monitoring and strict postoperative glucose control.
引用
- Wang SH, Xu C, Tan TL, et al. Increased Postoperative Glucose Variability Is Associated With Adverse Outcome Following Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection. J Arthroplasty. 2019. PMID: 31932102. doi:10.1016/j.arth.2019.11.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。